Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
Medindia,
, /PRNewswire/ -- Hoba Therapeutics, a Novo Holdings-founded Danish biotech company dedicated to developing novel therapeutic…